scorecardresearch
Thursday, September 11, 2025
TopicJ&J

Topic: J&J

J&J’s new flu drug flop shows how difficult it is to fight viruses

Johnson & Johnson stopped developing the drug pimodivir in the final stage of testing it for patients with influenza A, the most common cause of flu, after a study indicated it won't work.

Hip implants dent brand Johnson & Johnson, patients begin questioning other devices

Doctors say Johnson & Johnson's hip implant controversy is causing concern among Indian patients fitted with other devices from the company.

On Camera

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

‘Foreign policy rests on hard power’—from 1965 Indo-Pak war to Op Sindoor, key takeaways for India

A panel of experts moderated by ThePrint’s Editor-in-Chief Shekhar Gupta drew connections between insights of 1965 Indo-Pak War and strategic takeaways highlighted by Op Sindoor.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?